NCT02719782View on ClinicalTrials.gov

A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 2, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

December 31, 2019

Conditions
Recurrent Hepatocellular Carcinoma
Interventions
BIOLOGICAL

Biological: TCR-T

Autologous T cells transfected with mRNA encoding HBV antigen-specific TCR

Trial Locations (1)

510630

RECRUITING

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Agency for Science, Technology and Research

OTHER

collaborator

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

lead

Lion TCR Pte. Ltd.

INDUSTRY